Tag: HART CADhs

American Medical Association (AMA) Grants Prevencio Three CPT® PLA Reimbursement Codes for Novel AI-driven Cardiac HART® Blood Tests

Coronary/Structural Heart by 0 comments

Receipt of dedicated CPT® codes mark important commercialization milestone to pursue reimbursement for Prevencio’s multi-protein HART CADhs®, HART CVE®, and HART KD® Blood Tests KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc., The AI-driven Cardiac Company™, today announces that the American Medical Association (AMA) has assigned […]

Continue Reading →

Prevencio’s AI-driven HART CADhs Blood Test Significantly More Accurate than Troponin for Heart Disease Diagnosis in Diabetic Patients

Coronary/Structural Heart by 0 comments

Multinational study data highlighted at 2021 American Heart Association (AHA) Scientific Sessions November 16, 2021 09:00 AM Eastern Standard Time KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc. today announces the presentation of multinational patient data demonstrating its HART CADhs blood test is significantly more accurate than […]

Continue Reading →

Prevencio Announces Highly Accurate, AI-driven Blood Test with High Sensitivity (hs) Cardiac Troponin for the Diagnosis of Heart Disease

Coronary/Structural Heart by 0 comments

HART CADhs test addresses up to 30% of Emergency Department (ED) chest pain patients who cannot safely be ruled-in nor ruled-out for heart attack KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc. today announces data confirming the high accuracy of its AI-driven, multiple-protein HART CADhs […]

Continue Reading →